体外模型研究:氨甲环酸对脂肪细胞分化的影响
该体外研究将人皮下脂肪组织置于三维系统,用0、5、10、100、1000μg/mL氨甲环酸(TXA)处理,评估毛细血管出芽、脂肪祖细胞增殖、成脂分化与产热反应。结果显示临床相关浓度TXA不损害脂肪祖细胞活性、增殖、成脂分化或产热反应,支持其在吸脂与脂肪移植中的细胞安全性。
要点
- 临床相关浓度TXA不损害脂肪祖细胞活性与增殖。
- TXA不影响成脂分化及产热标志物表达。
- 早期毛细血管出芽短暂减弱,第5天已恢复。
核心结论
- 临床相关浓度TXA在体外不损害脂肪祖细胞活性、增殖、成脂分化或产热反应。
研究设计与样本
- 人皮下脂肪组织外植体三维培养,TXA浓度0、5、10、100、1000μg/mL。
- 第14天分离人脂肪毛细血管相关祖细胞(HACAPs)并行二维扩增。
- 另用独立HACAP系平行评估,成脂分化用标准分化培养基诱导。
主要发现
- TXA浓度升高与早期(≤4天)毛细血管出芽短暂减弱相关,第5天已恢复且此后无持续差异。
- 各TXA组HACAP产量、增殖速率与细胞形态均与对照相当。
- 脂滴形成及AdipoQ、PLIN1、FABP4表达在各组间无差异。
- forskolin刺激后UCP1、LINC473、DIO2表达在各条件下均无变化。
临床怎么用
- 为吸脂与脂肪移植中TXA的细胞安全性提供体外依据。
- 支持在整形与重建手术中继续扩大TXA应用。
局限性
- 研究为体外模型,结论需体内研究进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Tranexamic acid (TXA) is widely used in plastic surgery to reduce perioperative blood loss, hematoma formation, and postoperative ecchymosis. Its incorporation into tumescent solution for liposuction and fat grafting has increased; however, the effects of TXA on adipose tissue biology and progenitor cell function remain incompletely understood. METHODS: Human subcutaneous adipose tissue explants were cultured in a 3-dimensional system with vehicle control (0), 5, 10, 100, and 1000μg/mL TXA. Capillary sprouting was assessed from days 4 to 11. After 14 days, human adipose capillary-associated progenitor cells (HACAPs) were isolated from explants and expanded in 2-dimensional culture under identical TXA conditions. An independent HACAP line derived from panniculectomy tissue was evaluated in parallel. Cell proliferation was assessed over 2 to 3 expansion cycles. Adipogenic differentiation was induced using standard differentiation media and evaluated by lipid accumulation and RT-qPCR for adipogenic markers (AdipoQ, PLIN1, FABP4). Thermogenic responsiveness was assessed after forskolin stimulation by measuring expression of UCP1, LINC473, and DIO2. RESULTS: Increasing TXA concentrations were associated with a transient attenuation of early capillary sprouting at early time points (≤4d); this effect resolved by day 5, with no sustained differences in sprouting thereafter. HACAP yield, proliferation rates, and cellular morphology were comparable across all treatment groups. Adipogenic differentiation, as assessed by lipid droplet formation and expression of adipogenic genes, did not differ between TXA-treated and control cells. After thermogenic stimulation, expression of thermogenic markers was similarly unchanged across all conditions. CONCLUSIONS: Clinically relevant concentrations of TXA do not impair adipose progenitor cell viability, proliferation, adipogenic differentiation, or thermogenic responsiveness in vitro. These findings support the cellular safety of TXA use in liposuction and fat grafting and provide reassurance as adoption of TXA continues to expand in plastic and reconstructive surgery.
引用
- Ellis G, DeSouza T, Challagonda J, et al. Investigating the Influence of Tranexamic Acid on Adipocyte Differentiation in an In Vitro Model. Ann Plast Surg. 2026. PMID: 41885773. doi:10.1097/SAP.0000000000004702
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。